Steven Petrou
Founder at PRAXIS PRECISION MEDICINES, INC.
Steven Petrou active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 2017-12-31 | - |
| Founder | 2015-09-21 | - | |
RogCon, Inc.
 RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Chief Tech/Sci/R&D Officer | - | - |
| Founder | - | - |
Career history of Steven Petrou
Former positions of Steven Petrou
| Companies | Position | Start | End |
|---|---|---|---|
The Florey Institute of Neuroscience & Mental Health
 The Florey Institute of Neuroscience & Mental Health Miscellaneous Commercial ServicesCommercial Services The Florey Institute of Neuroscience & Mental Health operates as brain research center. Its teams work on a range of serious diseases including stroke, epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, motor neuron disease, traumatic brain and spinal cord injury, depression, schizophrenia, mental illness and addiction. The company was founded in July 2007 and is headquartered in Parkville, Australia. | Director/Board Member | 2018-06-30 | 2022-10-31 |
| Corporate Officer/Principal | 2018-06-30 | 2022-10-31 |
Training of Steven Petrou
| University of Melbourne | Doctorate Degree |
Statistics
International
| Australia | 3 |
| United States | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
The Florey Institute of Neuroscience & Mental Health
The Florey Institute of Neuroscience & Mental Health Miscellaneous Commercial ServicesCommercial Services The Florey Institute of Neuroscience & Mental Health operates as brain research center. Its teams work on a range of serious diseases including stroke, epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, motor neuron disease, traumatic brain and spinal cord injury, depression, schizophrenia, mental illness and addiction. The company was founded in July 2007 and is headquartered in Parkville, Australia. | Commercial Services |
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Health Technology |
- Stock Market
- Insiders
- Steven Petrou
- Experience
